Chemomab Therapeutics
(NASDAQ:CMMB)
$1.96
At close: Dec 6(Delayed 15-Minutes)
Get Real Time Here
$1.98
0.0200[1.02%]
PreMarket: 8:00AM EDT
Day Range- - -52 Wk Range1.750 - 8.760Open / Close- / -Float / Outstanding8.110M / 11.526M
Vol / Avg.0 / 41.084KMkt Cap22.590MP/E-50d Avg. Price2.120
Div / Yield (Forward)- / -%Payout Ratio-Total Float8.110MEPS-2.140

Chemomab Therapeutics Stock (NASDAQ:CMMB), Earnings Estimates, EPS, and Revenue

Chemomab Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.

Earnings Date

Nov 11

EPS

$-0.700

Quarterly Revenue

$0K

Annual Revenue (as of Sep 30)

Earnings History

Analyze the earnings history of Chemomab Therapeutics using advanced sorting and filters.

Date
time
Quarter
Prior EPS
Est EPS
Actual EPS
EPS Surprise
Prior Rev
Est Rev
Actual Rev
Rev Surprise
Get Alert
Q

When is Chemomab Therapeutics (NASDAQ:CMMB) reporting earnings?

A

Chemomab Therapeutics (CMMB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on November 11, 2022 for Q3.

Q

What were the latest earnings per share (EPS) for Chemomab Therapeutics (NASDAQ:CMMB)?

A

Chemomab Therapeutics (CMMB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 13, 2021 for Q1 and the Actual EPS was $-0.22, which beat the estimate of $-0.34.

Q

What were Chemomab Therapeutics’s (NASDAQ:CMMB) revenues?

A

Chemomab Therapeutics (CMMB) does not have any upcoming earnings reports scheduled yet. The last reported earnings were for reported on May 13, 2021 for Q1 and the Actual Revenue was $0K, which hit the estimate of $0K.

Browse earnings estimates, EPS, and revenue on all stocks.